DE69627150D1 - Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern - Google Patents
Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpernInfo
- Publication number
- DE69627150D1 DE69627150D1 DE69627150T DE69627150T DE69627150D1 DE 69627150 D1 DE69627150 D1 DE 69627150D1 DE 69627150 T DE69627150 T DE 69627150T DE 69627150 T DE69627150 T DE 69627150T DE 69627150 D1 DE69627150 D1 DE 69627150D1
- Authority
- DE
- Germany
- Prior art keywords
- cfa
- family
- consensus
- peptide
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091064702 1 family Proteins 0.000 title 1
- 241000894006 Bacteria Species 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/460,617 US5914114A (en) | 1995-06-02 | 1995-06-02 | Method of raising antibodies against E. coli of the family CS4-CFA/I |
PCT/US1996/008730 WO1996038171A1 (en) | 1995-06-02 | 1996-06-03 | Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69627150D1 true DE69627150D1 (de) | 2003-05-08 |
DE69627150T2 DE69627150T2 (de) | 2004-01-29 |
Family
ID=23829417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69627150T Expired - Lifetime DE69627150T2 (de) | 1995-06-02 | 1996-06-03 | Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern |
Country Status (8)
Country | Link |
---|---|
US (1) | US5914114A (de) |
EP (1) | EP0831900B1 (de) |
AT (1) | ATE235916T1 (de) |
CA (1) | CA2223013C (de) |
DE (1) | DE69627150T2 (de) |
DK (1) | DK0831900T3 (de) |
ES (1) | ES2196155T3 (de) |
WO (1) | WO1996038171A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU734532B2 (en) * | 1996-04-19 | 2001-06-14 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
DE69737233D1 (de) * | 1996-08-02 | 2007-02-22 | Us Army | Monoklonaler antikörper für die agglutinierung von e. coli, das ein protein der cs4/cfa-familie enthält |
US7404961B2 (en) * | 1996-08-02 | 2008-07-29 | The United States Of America As Represented By The Secretary Of The Army | Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins |
US7094883B1 (en) * | 1996-08-02 | 2006-08-22 | The United States Of America As Represented By The Secretary Of The Army | Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein |
JP4484968B2 (ja) * | 1996-08-02 | 2010-06-16 | デパートメント オブ ジ アーミー, ユー.エス. ガバメント | Cs4―cfa/iファミリータンパク質のコンセンサスペプチドに対する抗体に応答性のペプチド |
US6797276B1 (en) * | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US7422747B2 (en) * | 1997-10-07 | 2008-09-09 | Loma Linda University | Transgenic plant-based vaccines |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
AU4188100A (en) * | 1999-04-08 | 2000-11-14 | Gregory M. Glenn | Dry formulation for transcutaneous immunization |
AU6100500A (en) * | 1999-07-15 | 2001-02-05 | Med Immune, Inc. | Fima pilus-based vaccines |
AU7304000A (en) * | 1999-09-22 | 2001-04-24 | Isis Innovation Limited | Virulence gene and protein, and their use |
AU2001255543B2 (en) * | 2000-04-20 | 2005-06-23 | University Of Maryland, Baltimore | Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
IES20010042A2 (en) * | 2001-01-19 | 2002-12-11 | Enfer Technology Ltd | Test for transmissible spongiform encephalopathies |
US7527802B2 (en) * | 2001-02-13 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
EP1481053B1 (de) * | 2002-02-25 | 2007-09-12 | US Army Medical Research & Materiel Command | Verfahren zur herstellung von cs6-antigenimpfstoff zur behandlung, vorbeugung oder hemmung enterotoxigener escherichia coli-infektionen |
JP5389438B2 (ja) * | 2005-05-24 | 2014-01-15 | アメリカ合衆国 | 抗アドヘシンに基づく受動免疫予防物の製造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4411888A (en) * | 1981-06-22 | 1983-10-25 | The University Of Rochester | Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli |
US4443549A (en) * | 1981-10-19 | 1984-04-17 | Molecular Genetics, Inc. | Production of monoclonal antibodies against bacterial adhesins |
US4971794A (en) * | 1982-09-02 | 1990-11-20 | Unilever Patent Holdings B.V. | Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili |
US5417986A (en) * | 1984-03-16 | 1995-05-23 | The United States Of America As Represented By The Secretary Of The Army | Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
US5017372A (en) * | 1986-04-14 | 1991-05-21 | Medicis Corporation | Method of producing antibody-fortified dry whey |
ES2042718T3 (es) * | 1987-10-26 | 1993-12-16 | Akzo Nv | Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli. |
US5190746A (en) * | 1989-05-10 | 1993-03-02 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Plaque inhibiting oligosaccharide |
US5071977A (en) * | 1989-05-10 | 1991-12-10 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Plaque inhibiting oligosaccharide |
AU8417191A (en) * | 1990-07-24 | 1992-02-18 | Emory University | Production of and compositions for the major cs1 pilin antigen including vaccines and diagnostic probes |
US5698416A (en) * | 1995-06-02 | 1997-12-16 | The United States Of America As Represented By The Secretary Of The Army | Methods for production of antigens under control of temperature-regulated promotors in enteric bacteria |
US5637576A (en) * | 1995-06-05 | 1997-06-10 | Synsorb Biotech, Inc. | Treatment of traveller's diarrhea |
US5627163A (en) * | 1995-06-05 | 1997-05-06 | Synsorb Biotech, Inc. | Treatment of traveller's diarrhea |
-
1995
- 1995-06-02 US US08/460,617 patent/US5914114A/en not_active Expired - Lifetime
-
1996
- 1996-06-03 DE DE69627150T patent/DE69627150T2/de not_active Expired - Lifetime
- 1996-06-03 ES ES96918041T patent/ES2196155T3/es not_active Expired - Lifetime
- 1996-06-03 CA CA2223013A patent/CA2223013C/en not_active Expired - Fee Related
- 1996-06-03 WO PCT/US1996/008730 patent/WO1996038171A1/en active IP Right Grant
- 1996-06-03 EP EP96918041A patent/EP0831900B1/de not_active Expired - Lifetime
- 1996-06-03 AT AT96918041T patent/ATE235916T1/de not_active IP Right Cessation
- 1996-06-03 DK DK96918041T patent/DK0831900T3/da active
Also Published As
Publication number | Publication date |
---|---|
DE69627150T2 (de) | 2004-01-29 |
US5914114A (en) | 1999-06-22 |
WO1996038171A1 (en) | 1996-12-05 |
EP0831900A4 (de) | 1999-01-20 |
EP0831900B1 (de) | 2003-04-02 |
ES2196155T3 (es) | 2003-12-16 |
CA2223013A1 (en) | 1996-12-05 |
DK0831900T3 (da) | 2003-07-21 |
ATE235916T1 (de) | 2003-04-15 |
EP0831900A1 (de) | 1998-04-01 |
CA2223013C (en) | 2011-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69627150D1 (de) | Verfahren zur herstellung von gegen e.coli bakterien der familie cs4-cfa/1 gerichteten antikörpern | |
KR890006668A (ko) | 폴리펩티드 | |
DE69333802T8 (de) | Äusseres membranprotein von haemophilus | |
ATE170630T1 (de) | Proteine mit geänderten epitopen und verfahren zur deren herstellung | |
ATE421587T1 (de) | Neue escherichia coli-stämme, methoden zu deren herstellung und benutzung dieser in fermentationsprozessen zur produktion von l- threonin | |
DE69839425D1 (de) | Nukleinsäure bindende proteine | |
DE69840195D1 (de) | Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1 | |
DE69018142D1 (de) | Stressproteine aus Pilzen. | |
DE69636720D1 (de) | Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung | |
DE59101889D1 (de) | Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie. | |
DE69227994T2 (de) | Peptidzusammensetzung von exoenzym s von pseudomonas und verfahren zu deren erstellung | |
DE69018926T2 (de) | Vakzine gegen Bordetella. | |
ATE184612T1 (de) | Peptidzusammensetzung aus pseudomonas und methode diese herzustellen | |
DE3884316D1 (de) | Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung. | |
ATE227307T1 (de) | Verfahren zur herstellung modifizierten proteine | |
DK38889D0 (da) | Onkogen-indkodet polypeptid med vaekstfaktoraktivitet | |
EP0312157A3 (de) | Tetrapeptid-Renin-Inhibitoren mit C-terminalen Aminosäureamiden | |
ATE290088T1 (de) | Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms | |
DE69737007D1 (de) | Protein-disulfidisomerase-Gen eines methylotrophen Hefestammes | |
AU6306390A (en) | Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays | |
CA2262893A1 (en) | Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins | |
ATE76081T1 (de) | Verfahren zur herstellung von dipeptiden mit nterminalen nichtproteinogenen aminosaeuren. | |
ATE102950T1 (de) | Verfahren zur herstellung von dipeptiden mit cterminalen nicht-proteinogenen aminosaeuren. | |
WO2005019407A3 (en) | Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |